These preclinical findings could lead ... Single-Dose Gene Therapy Is Potentially Life-Changing for Adults With Hemophilia B Sep. 25, 2024 — Adults with hemophilia B saw their number of bleeding ...

4D Molecular Therapeutics, Inc. (NASDAQ:FDMT) is a clinical-stage biopharmaceutical company that specializes in gene therapy ...

With the rapid development of antibiotics in the 1930s, phage therapy -- using viruses known as bacteriophages or phages to tackle bacterial infections -- fell into oblivion. But as the current rise ...

Chromosomal instability plays a crucial role in the progression of cancer: it shapes the properties of tumor cells and drives ...

Chronic obstructive pulmonary disease (COPD) affects nearly 12 million people in the U.S. alone and is the third leading ...

A large, multiyear study conducted by Illumina, Providence, and Microsoft Research has shown that a comprehensive genomic profiling (CGP) panel, which can assess more than 500 genetic variations in ...

Discover a recent clinical trial that explored the efficacy of combining pembrolizumab, an anti-PD-1 immunotherapy, with ...

UCSF Benioff Children’s Hospital Oakland is enrolling patients in an innovative clinical trial that seeks to cure sickle cell ...

Hollings researchers will develop AI-driven tools to better match cancer patients to marketed therapies and clinical trials.

A Reuters report on Friday revealed that FDA researchers have found additional molecular evidence tying blockbuster asthma ...

The POLAR genomic signature can help predict the patients with early breast cancer who may benefit from adjuvant radiotherapy ...